mutLBSgeneDB |
Gene summary for FHL2 |
![]() |
Basic gene Info. | Gene symbol | FHL2 |
Gene name | four and a half LIM domains 2 | |
Synonyms | AAG11|DRAL|FHL-2|SLIM-3|SLIM3 | |
Cytomap | UCSC genome browser: 2q12.2 | |
Type of gene | protein-coding | |
RefGenes | NM_001039492.2, NM_001450.3,NM_201555.1,NM_201557.3,NM_201556.1, | |
Description | LIM domain protein DRALaging-associated gene 11down-regulated in rhabdomyosarcoma LIM proteinfour and a half LIM domains protein 2skeletal muscle LIM-protein 3 | |
Modification date | 20141207 | |
dbXrefs | MIM : 602633 | |
HGNC : HGNC | ||
Ensembl : ENSG00000115641 | ||
HPRD : 04026 | ||
Vega : OTTHUMG00000153120 | ||
Protein | UniProt: Q14192 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_FHL2 | |
BioGPS: 2274 | ||
Pathway | NCI Pathway Interaction Database: FHL2 | |
KEGG: FHL2 | ||
REACTOME: FHL2 | ||
Pathway Commons: FHL2 | ||
Context | iHOP: FHL2 | |
ligand binding site mutation search in PubMed: FHL2 | ||
UCL Cancer Institute: FHL2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 15692560 | GO:0043066 | negative regulation of apoptotic process | 15692560 |
Top |
Ligand binding site mutations for FHL2 |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | C132 | R131S | STAD | 1 | C10 | E12K | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for FHL2 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C132 | R131S | -0.58492364 | C10 | E12K | -0.35625869 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for FHL2 |
![]() |
![]() |
Top |
Top |
Phenotype information for FHL2 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C1458155 | Breast Neoplasms | 2 | AlteredExpression, Biomarker |
umls:C0023467 | Leukemia, Myeloid, Acute | 2 | Biomarker |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for FHL2 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 2miu | A | C10 |
Top |
Conservation information for LBS of FHL2 |
![]() |
LBS | AA sequence | # species | Species | C10 | FDCHHCNESLY | 2 | Mus musculus, Rattus norvegicus | C10 | FDCHHCNESLF | 1 | Homo sapiens | C10 | FDCHHCEDSLF | 1 | Bos taurus | C101 | EYSSKCQECKK | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C101 | EYSSRCQECKK | 1 | Bos taurus | C104 | SKCQECKKTIM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C104 | SRCQECKKSIM | 1 | Bos taurus | C126 | SWHETCFICHR | 2 | Homo sapiens, Bos taurus | C126 | SWHETCFTCQR | 2 | Mus musculus, Rattus norvegicus | C129 | ETCFICHRCQQ | 2 | Homo sapiens, Bos taurus | C129 | ETCFTCQRCQQ | 2 | Mus musculus, Rattus norvegicus | C132 | FICHRCQQPIG | 2 | Homo sapiens, Bos taurus | C132 | FTCQRCQQPIG | 2 | Mus musculus, Rattus norvegicus | C150 | ENQNFCVPCYE | 2 | Mus musculus, Rattus norvegicus | C150 | DNQNFCVPCYE | 1 | Homo sapiens | C150 | DSENFCVPCYE | 1 | Bos taurus | C153 | NFCVPCYEKQY | 2 | Mus musculus, Rattus norvegicus | C153 | NFCVPCYEKQH | 1 | Homo sapiens | C153 | NFCVPCYERQY | 1 | Bos taurus | C162 | QYALQCVQCKK | 3 | Bos taurus, Mus musculus, Rattus norvegicus | C162 | QHAMQCVQCKK | 1 | Homo sapiens | C165 | LQCVQCKKPIT | 3 | Bos taurus, Mus musculus, Rattus norvegicus | C165 | MQCVQCKKPIT | 1 | Homo sapiens | C185 | PWHKECFVCTA | 2 | Homo sapiens, Mus musculus | C185 | PWHRECFVCTA | 2 | Bos taurus, Rattus norvegicus | C188 | RECFVCTACKK | 2 | Bos taurus, Rattus norvegicus | C188 | KECFVCTACRK | 1 | Homo sapiens | C188 | KECFVCTACKK | 1 | Mus musculus | C191 | FVCTACKKQLS | 2 | Mus musculus, Rattus norvegicus | C191 | FVCTACRKQLS | 1 | Homo sapiens | C191 | FVCTACKKPLS | 1 | Bos taurus | C209 | DEFPYCLTCFC | 2 | Mus musculus, Rattus norvegicus | C209 | DDFAYCLNCFC | 1 | Homo sapiens | C209 | DEFAYCLGCFC | 1 | Bos taurus | C212 | PYCLTCFCDLY | 2 | Mus musculus, Rattus norvegicus | C212 | AYCLNCFCDLY | 1 | Homo sapiens | C212 | AYCLGCFCDLY | 1 | Bos taurus | C221 | LYAKKCAGCTN | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C221 | LYAKKCAGCAN | 1 | Bos taurus | C224 | KKCAGCTNPIS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C224 | KKCAGCANPIS | 1 | Bos taurus | C248 | QWHNDCFNCKK | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | C251 | NDCFNCKKCSL | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | C254 | FNCKKCSLSLV | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | C272 | RDDILCPDCGK | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | C275 | ILCPDCGKDI | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | C28 | EENPHCVACFE | 2 | Mus musculus, Rattus norvegicus | C28 | EESPYCVVCFE | 1 | Homo sapiens | C28 | EEQPYCVACFE | 1 | Bos taurus | C31 | PHCVACFEELY | 2 | Mus musculus, Rattus norvegicus | C31 | PYCVVCFETLF | 1 | Homo sapiens | C31 | PYCVACFEALF | 1 | Bos taurus | C40 | LYANTCEECGT | 2 | Mus musculus, Rattus norvegicus | C40 | LFANTCEECGK | 1 | Homo sapiens | C40 | LFASTCEECGK | 1 | Bos taurus | C43 | NTCEECGTPIG | 2 | Mus musculus, Rattus norvegicus | C43 | NTCEECGKPIG | 1 | Homo sapiens | C43 | STCEECGKLIG | 1 | Bos taurus | C65 | HWHEGCFHCSR | 2 | Mus musculus, Rattus norvegicus | C65 | HWHEACFHCSQ | 1 | Homo sapiens | C65 | HWHEACFHCSR | 1 | Bos taurus | C7 | TERFDCHHCNE | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C7 | TERFDCHHCED | 1 | Bos taurus | H123 | KGSSWHETCFI | 2 | Homo sapiens, Bos taurus | H123 | KGSSWHETCFT | 2 | Mus musculus, Rattus norvegicus | H182 | REQPWHKECFV | 2 | Homo sapiens, Mus musculus | H182 | REQPWHRECFV | 1 | Bos taurus | H182 | RDQPWHRECFV | 1 | Rattus norvegicus | H245 | EERQWHNDCFN | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | H62 | KDRHWHEACFH | 2 | Homo sapiens, Bos taurus | H62 | KDRHWHEGCFH | 2 | Mus musculus, Rattus norvegicus |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |